Research News
BrightFocus Foundation, a nonprofit and premier source of research funding to defeat Alzheimer’s, macular degeneration, and glaucoma, today was acknowledged as the catalyst behind a major advance in drug development for Alzheimer’s disease.
Macular Degeneration Research grantees are looking at new ways to stop age-related macular degeneration. Two, in particular, are hoping that vitamins and diet will provide solutions.
Learn about an exciting citizen science project receiving support from the BrightFocus Alzheimer’s Disease Research program; the first crowd-sourced effort to gather data to help end Alzheimer’s disease.
Top U.S. scientists are concerned that eye and vision health are relatively absent from national health priority lists. AMD, in particular, is rising..
An experimental drug, consisting of cells manufactured and implanted in the eye to stimulate optic nerve growth and activity, could be an entirely new way of fighting glaucoma.